Streetbeat News

Products Services

TSLA

U.S. automakers, including Tesla, General Motors, Toyota, and Ford, have shown strong sales performance in 2023, with GM leading as the top-selling automaker in the U.S. Tesla achieved its target of 1.8 million deliveries, while GM reported its best vehicle sales since 2019. Toyota's U.S. sales rose due to demand for its SUVs and sedans, and Ford's sales increased with pickups and SUVs. GM's total sales were 2.6 million units, a 14.1% increase from the previous year, and its EV sales constituted 2.9% of its total sales. GM aims to boost EV sales with increased production and incentives.

Portfolio Pulse from Upwallstreet

January 05, 2024 | 2:55 pm

DKNG

The arrival of Lionel Messi to Inter Miami has led to a significant increase in betting activity on Major League Soccer, particularly on Inter Miami matches and Messi-related bets. Bet365 reported that betting on Inter Miami was 'exponentially massive' and often increased 'by thousand-fold.' Messi's impact on betting was more significant than on the overall match and other soccer betting markets. DraftKings Inc (NASDAQ:DKNG) also acknowledged Messi's influence, with CEO Jason Robins predicting a big change for MLS due to Messi. Both Bet365 and DraftKings offered boosted bets on Messi and Inter Miami.

Portfolio Pulse from Chris Katje

January 05, 2024 | 2:34 pm

NVS

Novartis has received FDA approval for its new radioligand therapy (RLT) manufacturing facility in Indianapolis, which is now the largest and most advanced of its kind. The facility will increase RLT production capacity to 250,000 doses in 2024, ensuring an unconstrained supply of Pluvicto and Lutathera for current and future demand. Novartis has also doubled weekly production of Pluvicto, allowing treatment within two weeks of diagnosis. The company is expanding its global RLT manufacturing network, including new facilities in Japan and China, and aims to improve patient access by adding more treatment sites.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:31 pm

NTRB

Nutriband Inc. has signed a commercial development and clinical supply agreement with Kindeva Drug Delivery for Aversa Fentanyl, an abuse-deterrent fentanyl patch. This agreement will enable Kindeva to develop the manufacturing process and produce clinical supplies for FDA-required studies. Aversa Fentanyl, which combines Nutriband's proprietary technology with Kindeva's FDA-approved patch system, has a potential market of $80M - $200M in annual US sales. The technology aims to improve safety while ensuring access for patients in need.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:21 pm

ILMN

JNJ

Illumina is expanding its collaboration with Janssen Research & Development, a division of Johnson & Johnson, to advance the development of its Whole Genome Sequencing (WGS) Molecular Residual Disease (MRD) assay. This collaboration aims to enhance the utility of Illumina's WGS MRD test in cancer treatment by working with leading pharmaceutical companies.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:16 pm

NVO

A recent NIH-funded analysis revealed that patients treated with Semaglutide, a medication for obesity or type 2 diabetes, had a significantly lower risk of suicidal ideation, ranging from 49% to 73%, compared to those given other medications. This finding could have implications for the prescription practices for these conditions.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:06 pm

AAPL

AMT

COST

MSFT

SPCE

TSLA

Cryptocurrencies Bitcoin, Dogecoin, and Ethereum are experiencing a rebound amid renewed hopes for a spot ETF, with predictions of Bitcoin potentially reaching $57K. Apple Card has increased its Annual Percentage Yield from 4.25% to 4.35%. In US markets, investor sentiment is down ahead of the jobs report, with the Nasdaq falling for the fifth consecutive day. US politics are focused on Trump's influence and legal challenges. World politics highlight North Korea's military actions and Russia's procurement of missiles. The world economy sees a record-breaking tuna sale in Tokyo. In tech, Apple Card raises its yield, Microsoft phases out WordPad, and Apple suppliers invest to reduce Chinese dependence. Tesla faces recalls and strikes, while Costco sees a sales jump. American Tower sells Indian assets for $2.5B, and SpaceX sues the US Labor Board over layoffs.

Portfolio Pulse from Akanksha Bakshi

January 05, 2024 | 2:05 pm

AAPL

NVDA

TCEHY

TSM

Huawei's new laptop, the Qingyun L540, uses a 5-nanometer chip made by Taiwan Semiconductor Manufacturing Co (TSMC) in 2020, refuting claims of Chinese chipmaker SMIC's advanced fabrication capabilities. Despite U.S. sanctions, Huawei had previously released a smartphone with a 7nm processor by SMIC. Huawei's technological progress, including the Mate 60 smartphone, has helped it compete with companies like Apple and challenge Western tech reliance. Huawei's use of an older TSMC chip suggests stockpiling efforts due to U.S. restrictions. TSM shares saw a slight premarket decline.

Portfolio Pulse from Anusuya Lahiri

January 05, 2024 | 2:02 pm

SANA

Sana Biotechnology has received FDA clearance for its Investigational New Drug (IND) application for SC262, a hypoimmune-modified, CD22-directed allogeneic CAR T therapy. This therapy is aimed at treating patients with relapsed or refractory B-cell malignancies.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:00 pm

BABA

BIDU

Baidu, Inc's founder Robin Li has called for a shift from developing large language models to creating applications for existing models like Baidu's 'Ernie'. Despite this, competition in China's AI sector is increasing, with many homegrown models emerging. Baidu has faced challenges such as high executive turnover and internal conflicts, partly attributed to the joint presence of Li and his wife Melissa Ma. Baidu's focus on AI and large language models, including Ernie, is seen as crucial for its future amidst a crowded market and regulatory challenges. Alibaba Group Holding Limited's CEO also highlighted a shift towards AI, aiming to become an 'open technology platform'. Baidu's shares saw a slight decrease in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 05, 2024 | 1:54 pm